Suppr超能文献

维生素D补充剂与澳大利亚老年成年人白内障手术发生率

Vitamin D Supplementation and the Incidence of Cataract Surgery in Older Australian Adults.

作者信息

Rahman Sabbir T, Waterhouse Mary, Romero Briony Duarte, Baxter Catherine, English Dallas, Mackey David A, Ebeling Peter R, Armstrong Bruce K, McLeod Donald S A, Hartel Gunter, O'Connell Rachel L, van der Pols Jolieke C, Venn Alison J, Webb Penelope M, Whiteman David C, Neale Rachel E

机构信息

Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Melbourne School of Population Health, University of Melbourne, Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.

出版信息

Ophthalmology. 2023 Mar;130(3):313-323. doi: 10.1016/j.ophtha.2022.09.015. Epub 2022 Sep 27.

Abstract

PURPOSE

Observational studies suggest that higher serum 25-hydroxy vitamin D (25(OH)D) concentration may be associated with lower risk of cataract. However, no randomized controlled trials have assessed the effect of vitamin D supplementation on the incidence of cataract. We aimed to assess whether vitamin D supplementation reduces the incidence of cataract surgery.

DESIGN

We conducted an ancillary study of the D-Health Trial, a randomized, double-masked, placebo-controlled trial of monthly vitamin D conducted from 2014 through 2020 within the Australian general population.

PARTICIPANTS

We invited 421 207 men and women 60 to 84 years of age to participate; including an additional 1896 volunteers, 40 824 expressed interest. Those with hypercalcemia, hyperparathyroidism, kidney stones, osteomalacia, or sarcoidosis or those who were taking more than 500 international units (IU) supplemental vitamin D per day were excluded. A total of 21 315 were randomized, and 1390 participants did not fulfil the eligibility criteria for this analysis (linked data available, no cataract within first 6 months), leaving 19 925 included. The median follow-up was 5 years.

METHODS

Participants took 60 000 IU of vitamin D (n = 10 662) or placebo (n = 10 653) orally once per month for a maximum of 5 years.

MAIN OUTCOME MEASURES

The primary outcome for this analysis was the first surgical treatment for cataract, ascertained through linkage to universal health insurance records and hospital data.

RESULTS

Among 19 925 participants eligible for this analysis (mean age, 69.3 years; 46% women) 3668 participants (18.4%) underwent cataract surgery during follow-up (vitamin D: n = 1841 [18.5%]; placebo: n = 1827 [18.3%] ). The incidence of cataract surgery was similar between the two groups (incidence rate, 41.6 and 41.1 per 1000 person-years in the vitamin D and placebo groups, respectively; hazard ratio, 1.02; 95% confidence interval, 0.95-1.09). In prespecified subgroup analyses, the effect of vitamin D supplementation on the incidence of cataract surgery was not modified by age, sex, body mass index, predicted serum 25(OH)D concentration, or ambient ultraviolet radiation.

CONCLUSIONS

Routinely supplementing older adults who live in an area with a low prevalence of vitamin D deficiency with high-dose vitamin D is unlikely to reduce the need for cataract surgery.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

摘要

目的

观察性研究表明,较高的血清25-羟基维生素D(25(OH)D)浓度可能与较低的白内障风险相关。然而,尚无随机对照试验评估补充维生素D对白内障发病率的影响。我们旨在评估补充维生素D是否能降低白内障手术的发生率。

设计

我们对D-Health试验进行了一项辅助研究,该试验是2014年至2020年在澳大利亚普通人群中进行的一项关于每月补充维生素D的随机、双盲、安慰剂对照试验。

参与者

我们邀请了421207名60至84岁的男性和女性参与;包括另外1896名志愿者,40824人表示有兴趣。排除患有高钙血症、甲状旁腺功能亢进、肾结石、骨软化症或结节病的人,或每天服用超过500国际单位(IU)补充维生素D的人。共有21315人被随机分组,1390名参与者不符合本分析的纳入标准(有相关数据,前6个月内无白内障),最终纳入19925人。中位随访时间为5年。

方法

参与者每月口服一次60000IU维生素D(n = 10662)或安慰剂(n = 10653),最长持续5年。

主要观察指标

本分析的主要结局是首次白内障手术治疗,通过与全民健康保险记录和医院数据的关联来确定。

结果

在19925名符合本分析条件的参与者中(平均年龄69.3岁;46%为女性),3668名参与者(18.4%)在随访期间接受了白内障手术(维生素D组:n = 1841 [18.5%];安慰剂组:n = 1827 [18.3%])。两组白内障手术的发生率相似(维生素D组和安慰剂组的发病率分别为每1000人年41.6和41.1;风险比为1.02;95%置信区间为0.95 - 1.09)。在预先设定的亚组分析中,补充维生素D对白内障手术发生率的影响不受年龄、性别、体重指数、预测的血清25(OH)D浓度或环境紫外线辐射的影响。

结论

对于生活在维生素D缺乏患病率较低地区的老年人,常规补充高剂量维生素D不太可能减少白内障手术的需求。

财务披露

专有或商业披露信息可在参考文献之后找到。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验